Advanced
  Home Compare Reports

Comparison with Similar Reports

Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display (Color, B&W), Portability (Trolley, POC), Applicatio...

Publisher:        MarketsandMarkets

# of Pages:        270

Rating: 

1 User License $7,150

Publication Date:  January, 2022

Price:       $7,150 / User License




1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY USED FOR THE STUDY 35
1.5 MARKET STAKEHOLDERS 35
1.6 LIMITATIONS 36
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.1.1 Secondary sources 39
2.1.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
2.2.1 VENDOR REVENUE-BASED MARKET SIZE ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 42
2.2.2 END USER-BASED MARKET SIZE ESTIMATION 42
FIGURE 5 ULTRASOUND MARKET: END USER-BASED ESTIMATION 43
2.2.3 PRIMARY RESEARCH VALIDATION 43
2.3 COVID-19 HEALTH ASSESSMENT 43
2.4 COVID-19 ECONOMIC ASSESSMENT 44
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 44
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 44
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 45
2.6 DATA TRIANGULATION 46
FIGURE 8 DATA TRIANGULATION METHODOLOGY 46
2.7 RESEARCH ASSUMPTIONS 47
2.8 RESEARCH LIMITATIONS 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION) 48
FIGURE 10 ULTRASOUND MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026 49
FIGURE 11 ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2021 VS. 2026 (USD MILLION) 49
FIGURE 12 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 50
FIGURE 13 ULTRASOUND MARKET SHARE, BY END USER, 2021 VS. 2026 51
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ULTRASOUND MARKET 52
4 PREMIUM INSIGHTS 53
4.1 ULTRASOUND MARKET OVERVIEW 53
FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE ULTRASOUND MARKET 53
4.2 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE AND COUNTRY 54
FIGURE 16 GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE 54
4.3 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL ULTRASOUND MARKET 55
4.4 GEOGRAPHIC SNAPSHOT OF THE ULTRASOUND MARKET 55
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Increasing prevalence of target diseases 57
5.2.1.2 Rising patient preference for minimally invasive procedures 57
5.2.1.3 Technological advancements 58
TABLE 1 RECENT PRODUCT LAUNCHES/APPROVALS IN THE ULTRASOUND MARKET 58
5.2.1.4 Growing public and private investments, funding, and grants 59
5.2.1.5 Increasing number of diagnostic centers & hospitals 59
5.2.2 RESTRAINTS 60
5.2.2.1 Unfavorable healthcare reforms in the US 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Expanding applications of therapeutic ultrasound 60
5.2.3.2 Emerging markets 61
5.2.3.3 Development of POC ultrasound devices 61
5.2.4 CHALLENGES 62
5.2.4.1 Growing end-user preference for refurbished equipment 62
5.2.4.2 Dearth of skilled and well-trained sonographers 62
5.3 INDUSTRY TRENDS 62
5.3.1 DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES 62
5.3.2 GROWING USE OF ULTRASOUND IN ELASTOGRAPHY 63
5.3.3 INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS 63
5.4 PRICING TREND ANALYSIS (2017–2020) 64
5.4.1 NORTH AMERICA 64
5.4.2 EUROPE 64
5.4.3 ASIA PACIFIC 65
5.4.4 REST OF THE WORLD 65
5.5 VALUE CHAIN ANALYSIS 66
FIGURE 20 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 66
5.6 REGULATORY ANALYSIS 67
5.6.1 NORTH AMERICA 67
5.6.1.1 US 67
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION 67
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
5.6.1.2 Canada 68
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.6.2 EUROPE 70
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 71
5.6.3 ASIA PACIFIC 72
5.6.3.1 Japan 72
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 72
5.6.3.2 China 73
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
5.6.3.3 India 74
5.7 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 7 ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS 75
5.7.1 THREAT OF NEW ENTRANTS 75
5.7.2 THREAT OF SUBSTITUTES 75
5.7.3 BARGAINING POWER OF SUPPLIERS 76
5.7.4 BARGAINING POWER OF BUYERS 76
5.7.5 DEGREE OF COMPETITION 76
5.8 COVID-19 IMPACT ON THE ULTRASOUND MARKET 76
5.9 ECOSYSTEM COVERAGE: ULTRASOUND MARKET 78
5.10 PATENT ANALYSIS 79
FIGURE 23 TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021) 79
FIGURE 24 PATENT APPLICATIONS FOR ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 79
FIGURE 25 TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO AUGUST 2021) 80
FIGURE 26 PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 80
FIGURE 27 TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO AUGUST 2021) 81
FIGURE 28 PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND
(JANUARY 2011 TO DECEMBER 2021) 81
5.11 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 82
TABLE 8 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 82
TABLE 9 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 82
6 ULTRASOUND MARKET, BY TECHNOLOGY 83
6.1 INTRODUCTION 84
TABLE 10 ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 84
6.2 DIAGNOSTIC ULTRASOUND 84
TABLE 11 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION) 84
TABLE 12 DIAGNOSTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION) 85
6.2.1 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 85
TABLE 13 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 85
6.2.2 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 86
TABLE 14 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 86
6.2.3 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 86
TABLE 15 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 86
6.2.4 DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 87
TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 87
6.2.5 2D ULTRASOUND 87
6.2.5.1 Strong market demand from less-developed and emerging countries to sustain the growth of this segment 87
TABLE 17 2D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 88
6.2.6 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 88
TABLE 18 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 88
6.2.7 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 89
TABLE 19 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 89
6.2.8 2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
TABLE 20 2D ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
6.2.9 2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 90
TABLE 21 2D ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 90
6.2.10 3D AND 4D ULTRASOUND 90
6.2.10.1 Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound 90
TABLE 22 3D AND 4D ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 91
6.2.11 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 91
TABLE 23 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 91
6.2.12 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 92
TABLE 24 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 92
6.2.13 3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 92
TABLE 25 3D AND 4D ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 92
6.2.14 3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 93
TABLE 26 3D AND 4D ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 93
6.2.15 DOPPLER ULTRASOUND 93
6.2.15.1 Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth 93
TABLE 27 DOPPLER ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 94
6.2.16 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 94
TABLE 28 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 94
6.2.17 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 95
TABLE 29 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 95
6.2.18 DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 95
TABLE 30 DOPPLER ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 95
6.2.19 DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 96
TABLE 31 DOPPLER ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 96
6.3 THERAPEUTIC ULTRASOUND 96
TABLE 32 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019–2026 (USD MILLION) 96
TABLE 33 THERAPEUTIC ULTRASOUND MARKET, BY REGION,
2019–2026 (USD MILLION) 97
6.3.1 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 97
TABLE 34 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 97
6.3.2 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 98
TABLE 35 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 98
6.3.3 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 98
TABLE 36 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 98
6.3.4 THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 99
TABLE 37 THERAPEUTIC ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 99
6.3.5 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 99
6.3.5.1 Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL 99
TABLE 38 ESWL ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 100
6.3.6 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 100
TABLE 39 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 100
6.3.7 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 101
TABLE 40 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 101
6.3.8 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
TABLE 41 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
6.3.9 ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 102
TABLE 42 ESWL ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 102
6.3.10 HIGH-INTENSITY FOCUSED ULTRASOUND 102
6.3.10.1 Promising results associated with HIFU for the treatment of various cancers to drive market growth 102
TABLE 43 HIFU ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 103
6.3.11 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 103
TABLE 44 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 103
6.3.12 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 104
TABLE 45 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 104
6.3.13 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 104
TABLE 46 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 104
6.3.14 HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 105
TABLE 47 HIFU ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 105
 
7 ULTRASOUND MARKET, BY SYSTEM PORTABILITY 106
7.1 INTRODUCTION 107
TABLE 48 ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 107
7.2 TROLLEY/CART-BASED DEVICES 107
7.2.1 INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH 107
TABLE 49 ULTRASOUND MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 2019–2026 (USD MILLION) 108
7.3 COMPACT/TABLE-TOP DEVICES 108
7.3.1 DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES 108
TABLE 50 ULTRASOUND MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 2019–2026 (USD MILLION) 109
7.4 POC/PORTABLE DEVICES 109
7.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES 109
TABLE 51 ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION,
2019–2026 (USD MILLION) 110
8 ULTRASOUND MARKET, BY DISPLAY TYPE 111
8.1 INTRODUCTION 112
TABLE 52 ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 112
8.2 COLOR ULTRASOUND DEVICES 112
8.2.1 GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET 112
TABLE 53 COLOR ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 113
8.3 BLACK & WHITE ULTRASOUND DEVICES 113
8.3.1 ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES 113
TABLE 54 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 114
9 ULTRASOUND MARKET, BY APPLICATION 115
9.1 INTRODUCTION 116
TABLE 55 ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 116
9.2 RADIOLOGY/GENERAL IMAGING APPLICATIONS 116
9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 116
TABLE 56 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 117
9.3 CARDIOLOGY APPLICATIONS 117
9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 117
TABLE 57 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 118
9.4 OBSTETRICS/GYNECOLOGY APPLICATIONS 118
9.4.1 ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY 118
TABLE 58 ULTRASOUND MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 119
9.5 VASCULAR APPLICATIONS 119
9.5.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 119
TABLE 59 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 120
9.6 UROLOGICAL APPLICATIONS 120
9.6.1 ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS 120
TABLE 60 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 121
9.7 ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS 121
9.7.1 RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 121
TABLE 61 ULTRASOUND MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 122
9.8 PAIN MANAGEMENT APPLICATIONS 122
9.8.1 ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS 122
TABLE 62 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 123
9.9 OTHER APPLICATIONS 123
TABLE 63 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 123
10 ULTRASOUND MARKET, BY COMPONENT 124
10.1 INTRODUCTION 125
TABLE 64 ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 125
10.2 TRANSDUCERS/PROBES 125
TABLE 65 TRANSDUCERS/PROBES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 66 TRANSDUCERS/PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 126
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES 127
10.2.1.1 Growing adoption of POC ultrasound to drive the growth of this market segment 127
TABLE 67 CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION,
2019–2026 (USD MILLION) 127
10.2.2 LINER ARRAY PROBES 127
10.2.2.1 Increasing target patient population to drive the growth of this market segment 127
TABLE 68 LINEAR ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2.3 PHASED ARRAY PROBES 128
10.2.3.1 Technological advancements to drive the growth of this market segment 128
TABLE 69 PHASED ARRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2.4 OTHER PROBES 129
TABLE 70 OTHER PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 129
10.3 WORKSTATIONS 129
10.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 129
TABLE 71 WORKSTATIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 130
10.4 OTHER COMPONENTS 130
TABLE 72 OTHER COMPONENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 130
11 ULTRASOUND MARKET, BY END USER 131
11.1 INTRODUCTION 132
TABLE 73 ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 132
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 132
11.2.1 SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES 132
TABLE 74 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2019–2026 (USD MILLION) 133
11.3 MATERNITY CENTERS 134
11.3.1 INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH 134
TABLE 75 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION,
2019–2026 (USD MILLION) 134
11.4 AMBULATORY CARE CENTERS 135
11.4.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH 135
TABLE 76 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2026 (USD MILLION) 135
11.5 RESEARCH AND ACADEMIA 136
11.5.1 GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 136
TABLE 77 ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION,
2019–2026 (USD MILLION) 136
11.6 OTHER END USERS 137
FIGURE 29 NUMBER OF SPORTS INJURIES (2020) 137
TABLE 78 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 138
 
12 ULTRASOUND MARKET, BY REGION 139
12.1 INTRODUCTION 140
TABLE 79 ULTRASOUND MARKET, BY REGION, 2019–2026 (USD MILLION) 140
12.2 EUROPE 141
FIGURE 30 EUROPE: ULTRASOUND MARKET SNAPSHOT 141
TABLE 80 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 81 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 142
TABLE 82 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 83 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 84 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 143
TABLE 85 EUROPE: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 143
TABLE 86 EUROPE: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 87 EUROPE: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 144
TABLE 88 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 89 EUROPE: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 145
12.2.1 GERMANY 146
12.2.1.1 Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth 146
TABLE 90 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 146
TABLE 91 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 92 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
12.2.2 UK 147
12.2.2.1 Rising geriatric population to drive market growth in the UK 147
TABLE 93 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 148
TABLE 94 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 95 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
12.2.3 FRANCE 149
12.2.3.1 Modernization of healthcare infrastructure fueling the demand for ultrasound systems 149
TABLE 96 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 150
TABLE 97 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 98 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
12.2.4 ITALY 151
12.2.4.1 Improved reimbursement scenario and increasing R&D to support overall market growth 151
TABLE 99 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 151
TABLE 100 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 101 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
12.2.5 SPAIN 152
12.2.5.1 Low entry barriers to create opportunities for global players to expand their presence in the country 152
TABLE 102 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 153
TABLE 103 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 104 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
12.2.6 REST OF EUROPE 154
TABLE 105 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 106 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 107 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
12.3 NORTH AMERICA 156
TABLE 108 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
TABLE 109 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 156
TABLE 110 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 111 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 112 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 157
TABLE 113 NORTH AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 158
TABLE 114 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
TABLE 115 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 159
TABLE 116 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 117 NORTH AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 160
 
12.3.1 US 160
12.3.1.1 The US dominated the North American ultrasound market 160
TABLE 118 POCUS ULTRASOUND CPT CODES (2021) 161
TABLE 119 CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021) 164
TABLE 120 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 165
TABLE 121 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 122 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
12.3.2 CANADA 166
12.3.2.1 Growing awareness about early disease diagnosis to drive market growth in Canada 166
TABLE 123 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 167
TABLE 124 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 125 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
12.4 ASIA PACIFIC 168
FIGURE 31 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT 169
TABLE 126 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 170
TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 170
TABLE 128 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 129 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 130 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 171
TABLE 131 ASIA PACIFIC: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 171
TABLE 132 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 172
TABLE 134 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 135 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 173
12.4.1 CHINA 174
12.4.1.1 Increasing patient pool and localized manufacturing to drive the market growth 174
TABLE 136 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
TABLE 137 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 138 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
12.4.2 JAPAN 176
12.4.2.1 Rising geriatric population to boost market growth in Japan 176
TABLE 139 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 176
TABLE 140 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 141 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
12.4.3 INDIA 177
12.4.3.1 Significant burden of target diseases and availability of affordable devices to drive market growth 177
TABLE 142 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 178
TABLE 143 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 144 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
12.4.4 SOUTH KOREA 179
12.4.4.1 Supportive government initiatives in the country to positively impact market growth 179
TABLE 145 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 180
TABLE 146 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 147 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
12.4.5 AUSTRALIA 181
12.4.5.1 Growing research investments and awareness campaigns to drive market growth in Australia 181
TABLE 148 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO 181
TABLE 149 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 184
TABLE 150 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 151 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
12.4.6 REST OF ASIA PACIFIC 185
TABLE 152 ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 186
TABLE 153 ROAPAC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 154 ROAPAC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
 
12.5 LATIN AMERICA 187
TABLE 155 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 156 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 187
TABLE 157 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 158 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 159 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE,
2019–2026 (USD MILLION) 188
TABLE 160 LATIN AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 189
TABLE 161 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 189
TABLE 162 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 190
TABLE 163 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 164 LATIN AMERICA: ULTRASOUND MARKET, BY END USER,
2019–2026 (USD MILLION) 191
12.5.1 BRAZIL 191
12.5.1.1 Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis 191
TABLE 165 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 192
TABLE 166 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 167 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
12.5.2 MEXICO 193
12.5.2.1 Modernization of healthcare infrastructure to support market growth in Mexico 193
TABLE 168 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 193
TABLE 169 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 170 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
12.5.3 REST OF LATIN AMERICA 194
TABLE 171 ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 195
TABLE 172 ROLA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 173 ROLA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
 
12.6 MIDDLE EAST & AFRICA 196
12.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION 196
TABLE 174 MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 196
TABLE 175 MEA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 176 MEA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 177 MEA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019–2026 (USD MILLION) 197
TABLE 178 MEA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY,
2019–2026 (USD MILLION) 198
TABLE 179 MEA: ULTRASOUND MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 198
TABLE 180 MEA: ULTRASOUND MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 199
TABLE 181 MEA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 182 MEA: ULTRASOUND MARKET, BY END USER, 2019–2026 (USD MILLION) 200
13 COMPETITIVE LANDSCAPE 201
13.1 OVERVIEW 201
13.2 KEY PLAYER STRATEGIES 201
FIGURE 32 KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021) 202
13.3 REVENUE SHARE ANALYSIS 203
FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET 203
13.4 MARKET SHARE ANALYSIS: ULTRASOUND MARKET, BY KEY PLAYER (2020) 204
FIGURE 34 GE HEALTHCARE HELD THE LEADING POSITION IN THE ULTRASOUND MARKET IN 2020 204
TABLE 183 ULTRASOUND MARKET: DEGREE OF COMPETITION 205
13.5 COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020) 206
13.5.1 TERMINOLOGY/NOMENCLATURE 206
13.5.1.1 Stars 206
13.5.1.2 Emerging leaders 206
13.5.1.3 Pervasive players 206
13.5.1.4 Participants 206
FIGURE 35 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 207
13.6 COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020) 208
13.6.1 PROGRESSIVE COMPANIES 208
13.6.2 RESPONSIVE COMPANIES 208
13.6.3 DYNAMIC COMPANIES 208
13.6.4 STARTING BLOCKS 208
FIGURE 36 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING
(SME/START-UPS) 209
13.7 COMPETITIVE BENCHMARKING 210
TABLE 184 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN
THE ULTRASOUND MARKET 210
13.8 COMPETITIVE SCENARIO (2018–2021) 210
13.8.1 NEW PRODUCT LAUNCHES AND APPROVALS 210
TABLE 185 ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS,
2018–2021 210
13.8.2 DEALS 211
TABLE 186 ULTRASOUND MARKET: DEALS, 2018–2021 211
13.8.3 EXPANSIONS 212
TABLE 187 ULTRASOUND MARKET: EXPANSIONS, 2018–2021 212
14 COMPANY PROFILES 213
14.1 INTRODUCTION 213
14.2 KEY PLAYERS 214
(Business overview, Products offered, Recent developments, MNM view)*
14.2.1 GE HEALTHCARE 214
TABLE 188 GE HEALTHCARE: BUSINESS OVERVIEW 214
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 215
14.2.2 KONINKLIJKE PHILIPS N.V. 219
TABLE 189 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 219
FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 220
14.2.3 CANON MEDICAL SYSTEMS CORPORATION 224
TABLE 190 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW 224
FIGURE 39 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020) 225
14.2.4 SIEMENS AG 228
TABLE 191 SIEMENS AG: BUSINESS OVERVIEW 228
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 229
14.2.5 HITACHI, LTD. 232
TABLE 192 HITACHI, LTD.: BUSINESS OVERVIEW 232
FIGURE 41 HITACHI, LTD.: COMPANY SNAPSHOT 233
14.2.6 HOLOGIC, INC. 236
TABLE 193 HOLOGIC, INC.: BUSINESS OVERVIEW 236
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT 237
14.2.7 FUJIFILM HOLDINGS CORPORATION 239
TABLE 194 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 239
FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 240
14.2.8 SAMSUNG ELECTRONICS CO., LTD. 243
TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW 243
FIGURE 44 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 244
14.2.9 MINDRAY MEDICAL INTERNATIONAL LIMITED 247
TABLE 196 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 247
FIGURE 45 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT 247
14.2.10 ANALOGIC CORPORATION 250
TABLE 197 ANALOGIC CORPORATION: BUSINESS OVERVIEW 250
14.2.11 ESAOTE SPA 252
TABLE 198 ESAOTE S.P.A: BUSINESS OVERVIEW 252
14.2.12 CARESTREAM HEALTH 255
TABLE 199 CARESTREAM HEALTH: BUSINESS OVERVIEW 255
FIGURE 46 ONEX CORPORATION: COMPANY SNAPSHOT 255
14.2.13 CURA HEALTHCARE 257
TABLE 200 CURA HEALTHCARE: BUSINESS OVERVIEW 257
14.2.14 CHISON MEDICAL TECHNOLOGIES CO., LTD. 258
TABLE 201 CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW 258
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14.3 OTHER COMPANIES 260
14.3.1 MOBISANTE, INC. 260
14.3.2 NEUSOFT CORPORATION 261
14.3.3 CLARIUS MOBILE HEALTH 262
14.3.4 MEDGYN PRODUCTS, INC. 262
14.3.5 UNITED IMAGING HEALTHCARE CO., LTD. 263
14.3.6 PROMED TECHNOLOGY CO., LTD. 264
14.3.7 CEPHASONICS 265
14.3.8 UAB TELEMED 265
14.3.9 SHENZHEN RICSO TECHNOLOGY CO., LTD. 266
14.3.10 WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD. 267
15 APPENDIX 268
15.1 DISCUSSION GUIDE 268
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 273
15.3 AVAILABLE CUSTOMIZATIONS 275
15.4 RELATED REPORTS 276
15.5 AUTHOR DETAILS 277

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127